Rheumatology Therapeutics Market Size is Anticipated to Surpass Revenue of USD 65.1 Billion by 2034 at a Grow CAGR of 2.6% | Transparency Market Research Inc.
14 août 2024 17h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc.-, Aug. 14, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global rheumatology...
AI Therapeutics Announces Initiation of a Phase 2 Clinical Trial of LAM-001 for Treatment of Pulmonary Arterial Hypertension (PAH)
31 août 2023 10h38 HE
|
AI Therapeutics, Inc.
GUILFORD, Conn., Aug. 31, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the initiation...
Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
14 nov. 2017 07h00 HE
|
Neuronascent, Inc.
CLARKSVILLE, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today...